MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunome (IMNM) Earnings Date & Reports
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies... Show more
A.I. Advisor
published Earnings
IMNM is expected to report earnings to fall 7.28% to -60 cents per share on November 16
Q3'26
Est.
$-0.60
Q2'26
Missed
by $0.14
Q1'26
Beat
by $0.07
Q4'25
Missed
by $0.18
Q3'25
Missed
by $0.08
The last earnings report on August 11 showed earnings per share of -64 cents, missing the estimate of -51 cents. With 139.22K shares outstanding, the current market capitalization sits at 2.46B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 425 939-7410
Employees
177
Web
https://www.immunome.com